Vericel Corporation
US ˙ NasdaqGM ˙ US92346J1088

Introduksjon

Denne siden gir en grundig analyse av den kjente historikken for insidernes handelsaktiviteter for Kevin F Mclaughlin. Insidere er ledere, direktører eller betydelige investorer i et selskap. Det er ulovlig for insidere å gjøre handler i deres selskaper basert på spesifikke, ikke-offentlig informasjon. Dette betyr ikke at det er ulovlig for dem å gjøre noen handler i deres egne selskaper. Imidlertid må de rapportere alle handler til SEC via et skjema 4. Til tross for disse begrensningene, antyder akademisk forskning at insidere - generelt sett - har en tendens til å overgå markedet i sine egne selskaper.

Gjennomsnittlig handelslønnsomhet

Den gjennomsnittlige handelslønnsomheten er den gjennomsnittlige avkastningen av alle åpne markedskjøp gjort av insideren de siste tre årene. For å beregne dette, undersøker vi hvert eneste åpne marked, uplanlagte kjøp som er gjort av insideren, men dette inkluderer ikke alle handler som ble markert som en del av en 10b5-1 handelsplan. Vi beregner deretter gjennomsnittlig ytelse av disse handlene over 3, 6 og 12 måneder, gjennomsnittlig hver av disse varighetene for å generere en endelig ytelsesmåling for hver handel. Til slutt,

Dersom lønnsomheten for denne interne handelen er "N/A", har enten den interne personen ikke gjort noen åpen-markeds kjøp de siste tre årene, eller så er handlene for nylig til å beregne en pålitelig prestasjonsmåler.

Oppdateringsfrekvens: Daglig

Se listen over de mest lønnsomme insidetraderne.

Selskaper med rapporterte insiderposisjoner

SEC-arkiveringene indikerer at Kevin F Mclaughlin har rapporterte beholdninger av handler i følgende selskaper:

Verdipapir Navn Siste rapporterte høydepunkter
US:VCEL / Vericel Corporation Director 15 100
US:DBTX / Decibel Therapeutics Inc Director 0
US:XLRN / Acceleron Pharma Inc SVP, CFO and Treasurer 0
Hvordan tolke diagrammene

De følgende diagrammene viser aksjens ytelse etter hver åpen markedstransaksjon som ikke var planlagt, utført av Kevin F Mclaughlin. Ikke-planlagte handler er handler som ikke ble gjort som en del av en 10b5-1 handelsplan. Aksjeytelsen er kartlagt som kumulativ prosentendring i aksjekursen. For eksempel, hvis en innsidehandel ble gjort 1. januar 2019, vil diagrammet vise daglig prosentendring for verdipapiret til dagens dato. Dersom aksjeprisen går fra $10 til $15 i løpet av denne tiden, vil den kumulative prosentendringen i aksjeprisen være 50%. En endring i prisen fra $10 til $20 vil være 100%, og en endring i prisen fra $10 til $5 vil være - 50%.

Til syvende og sist er målet vårt å avgjøre hvor tett insidernes handler korrelerer med overavkastninger (positiv eller negativ) i aksjekursen for å se om insidere timer sine handler for å tjene på intern informasjon. Se for deg en situasjon der en insider gjør dette. I denne situasjonen, forventer vi enten (a) positive avkastninger etter kjøp, eller (b) negative avkastninger etter salg. I tilfelle (a) KJØP-diagrammet ville vise en serie av oppadgående kurver, som indikerer positive avkastninger etter hver kjøpstransaksjon. I tilfelle (b) ville SALG-diagrammet vise en serie av nedadgående kurver, som indikerer negative avkastninger etter hver salgstransaksjon.

Imidlertid er dette alene ikke nok til å dra konklusjoner. Hvis, for eksempel, aksjeprisen for selskapet steg jevnt over mange år uten å følge en syklisk trend, ville vi forventet at alle postkjøpsdiagrammer skal ha en stigende trend. På samme måte vil ikke-sykliske nedganger over mange år resultere i nedadgående trend i post-trade diagrammer. Ingen av disse diagrammene ville antyde aktiviteter som insidertrening.

Den sterkeste indikatoren ville vært en situasjon der aksjekursen var ekstremt syklisk, og det var både positive signaler i KJØPSdiagrammet og negative plot i SALGSdiagrammet. Denne situasjonen ville vært sterkt antydende om en insider som timet handler til sin økonomiske fordel.

Internkjøp VCEL / Vericel Corporation - Analyse av kortsiktig fortjeneste

I denne seksjonen analyserer vi lønnsomheten av hvert uplanlagt, åpen-marked internsalg som er gjort i VCEL / Vericel Corporation. Denne analysen hjelper til å forstå om den interne personen regelmessig genererer unormale avkastninger, og er verdt å følge. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.

Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.

Handelsdato Ticker Innsider Rapporterte
aksjer
Rapportert
pris
Justerte
aksjer
Justert
pris
Kostpris Dager til
maks
Pris ved
maks
Maks
fortjeneste ($)
Maks fortjeneste (%)
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen.

Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.

VCEL / Vericel Corporation Insider Trades
Internhandel VCEL / Vericel Corporation - Analyse av kortsiktig tap

I denne seksjonen analyserer vi unngåelsen av kortsiktig tap for hvert uplanlagt, åpen-marked internsalg som er gjort i VCEL / Vericel Corporation. Et jevnt mønster av tap unngåelse kan antyde at fremtidige salgstransaksjoner kan forutsi nedgang i pris. Denne analysen gjelder ett år etter hver handel, og resultatene er teoretiske.

Følgende tabell viser de mest nylige åpne markedskjøpene som ikke var en del av en handelsplan.

Handelsdato Ticker Innsider Rapporterte
aksjer
Rapportert
pris
Justerte
aksjer
Justert
pris
Kostpris Dager til
min
Pris ved
min
Maks tap
unngått ($)
Maks tap
unngått (%)
Det er ingen kjente uplanlagte handler på det åpne markedet for denne insideren og verdipapirkombinasjonen.

Justert pris er prisen justert for splitt. Justerte aksjer er aksjene justert for splitt.

VCEL / Vericel Corporation Insider Trades
Innsidernes handelshistorikk

Tabellen viser den komplette listen over innsidehandler gjort av Kevin F Mclaughlin som avslørt til Securies Exchange Comission (SEC).

Fildato Transaksjonsdato Skjema Ticker Verdipapir Kode 10b5-1 Aksjer Gjenværende aksjer Prosent
endring
Aksje
pris
Transaksjons
verdi
Gjenværende
verdi
2025-08-08 2025-08-06 4 VCEL Vericel Corp
Common Stock
S - Sale X −7 000 15 100 −31,67 35,92 −251 440 542 392
2025-08-08 2025-08-06 4 VCEL Vericel Corp
Common Stock
M - Exercise 7 000 22 100 46,36 2,76 19 320 60 996
2025-05-09 2025-05-07 4 VCEL Vericel Corp
Common Stock
S - Sale X −7 000 15 100 −31,67 39,98 −279 860 603 698
2025-05-09 2025-05-07 4 VCEL Vericel Corp
Common Stock
M - Exercise 7 000 22 100 46,36 2,76 19 320 60 996
2025-05-02 2025-04-30 4 VCEL Vericel Corp
Common Stock
M - Exercise 3 200 15 100 26,89
2025-02-14 2025-02-12 4 VCEL Vericel Corp
Common Stock
S - Sale X −1 000 11 900 −7,75 55,43 −55 430 659 617
2025-02-14 2025-02-12 4 VCEL Vericel Corp
Common Stock
M - Exercise 1 000 12 900 8,40 2,76 2 760 35 604
2025-02-14 2025-02-12 4 VCEL Vericel Corp
Common Stock
S - Sale X −6 000 11 900 −33,52 55,47 −332 820 660 093
2025-02-14 2025-02-12 4 VCEL Vericel Corp
Common Stock
M - Exercise 6 000 17 900 50,42 3,74 22 440 66 946
2024-11-15 2024-11-13 4 VCEL Vericel Corp
Common Stock
S - Sale X −7 000 11 900 −37,04 55,54 −388 780 660 926
2024-11-15 2024-11-13 4 VCEL Vericel Corp
Common Stock
M - Exercise 7 000 18 900 58,82 3,74 26 180 70 686
2024-08-09 2024-08-07 4 VCEL Vericel Corp
Common Stock
S - Sale X −2 000 11 900 −14,39 45,99 −91 980 547 281
2024-08-09 2024-08-07 4 VCEL Vericel Corp
Common Stock
M - Exercise 2 000 13 900 16,81 3,74 7 480 51 986
2024-08-09 2024-08-07 4 VCEL Vericel Corp
Common Stock
S - Sale X −5 000 11 900 −29,59 45,92 −229 600 546 448
2024-08-09 2024-08-07 4 VCEL Vericel Corp
Common Stock
M - Exercise 5 000 16 900 42,02 3,74 18 700 63 206
2024-05-03 2024-05-01 4 VCEL Vericel Corp
Common Stock
M - Exercise 3 200 11 900 36,78
2023-09-25 2023-09-25 4 DBTX Decibel Therapeutics, Inc.
Common Stock
D - Sale to Issuer −5 000 0 −100,00
2023-06-14 2023-06-13 4 DBTX Decibel Therapeutics, Inc.
Common Stock
A - Award 5 000 5 000
2023-04-28 2023-04-27 4 VCEL Vericel Corp
Common Stock
M - Exercise 2 600 8 700 42,62
2022-04-29 2022-04-27 4 VCEL Vericel Corp
Restricted Stock Unit
A - Award 2 600 2 600
2022-04-29 2022-04-27 4 VCEL Vericel Corp
Stock Option (right to buy)
A - Award 6 500 6 500
2022-04-29 2022-04-27 4 VCEL Vericel Corp
Restricted Stock Unit
M - Exercise −2 600 0 −100,00
2022-04-29 2022-04-27 4 VCEL Vericel Corp
Common Stock
M - Exercise 2 600 6 100 74,29
2021-11-22 2021-11-19 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
D - Sale to Issuer −18 806 0 −100,00
2021-11-22 2021-11-19 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
D - Sale to Issuer −24 334 0 −100,00
2021-11-22 2021-11-19 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
D - Sale to Issuer −20 500 0 −100,00
2021-11-22 2021-11-19 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
D - Sale to Issuer −11 262 0 −100,00
2021-11-22 2021-11-19 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
D - Sale to Issuer −2 663 0 −100,00
2021-11-22 2021-11-19 4 XLRN ACCELERON PHARMA INC
Common Stock
U - Other −10 681 0 −100,00
2021-09-24 2021-09-24 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −170 20 500 −0,82
2021-09-24 2021-09-24 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −5 200 11 262 −31,59
2021-09-24 2021-09-24 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −5 370 10 681 −33,46 160,38 −861 241 1 713 019
2021-09-24 2021-09-24 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 170 16 051 1,07 41,64 7 079 668 364
2021-09-24 2021-09-24 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 5 200 15 881 48,68 40,61 211 172 644 927
2021-09-24 2021-09-23 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −7 330 20 670 −26,18
2021-09-24 2021-09-23 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −9 800 16 462 −37,32
2021-09-24 2021-09-23 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −2 500 2 663 −48,42
2021-09-24 2021-09-23 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −983 10 681 −8,43 161,26 −158 519 1 722 418
2021-09-24 2021-09-23 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −18 647 11 664 −61,52 160,26 −2 988 368 1 869 273
2021-09-24 2021-09-23 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 7 330 30 311 31,90 41,64 305 221 1 262 150
2021-09-24 2021-09-23 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 9 800 22 981 74,35 40,61 397 978 933 258
2021-09-24 2021-09-23 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 2 500 13 181 23,41 30,17 75 425 397 671
2021-04-30 2021-04-28 4 VCEL Vericel Corp
Restricted Stock Unit
A - Award 2 600 2 600
2021-04-30 2021-04-28 4 VCEL Vericel Corp
Stock Option (right to buy)
A - Award 6 500 6 500
2021-04-30 2021-04-28 4 VCEL Vericel Corp
Restricted Stock Unit
M - Exercise −1 750 0 −100,00
2021-04-30 2021-04-28 4 VCEL Vericel Corp
Common Stock
M - Exercise 1 750 3 500 100,00
2021-02-02 2021-01-29 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 18 806 18 806
2021-02-02 2021-01-29 4 XLRN ACCELERON PHARMA INC
Common Stock
A - Award 4 868 10 681 83,74
2021-01-06 2021-01-05 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −4 5 813 −0,07 123,50 −494 717 906
2021-01-06 2021-01-05 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −296 5 817 −4,84 122,85 −36 364 714 618
2021-01-06 2021-01-05 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −499 6 113 −7,55 121,89 −60 823 745 114
2021-01-06 2021-01-05 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −700 6 612 −9,57 120,43 −84 301 796 283
2021-01-06 2021-01-04 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −300 7 312 −3,94 124,45 −37 335 909 978
2021-01-06 2021-01-04 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −667 7 612 −8,06 124,47 −83 021 947 466
2021-01-06 2021-01-04 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −600 8 279 −6,76 123,49 −74 094 1 022 374
2021-01-06 2021-01-04 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −200 8 879 −2,20 125,49 −25 098 1 114 226
2021-01-06 2021-01-04 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −713 9 079 −7,28 124,28 −88 612 1 128 338
2021-01-06 2021-01-04 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −800 9 792 −7,55 123,54 −98 832 1 209 704
2021-01-06 2021-01-04 4 XLRN ACCELERON PHARMA INC
Common Stock
F - Taxes −624 10 592 −5,56 124,31 −77 569 1 316 692
2020-12-15 2020-12-14 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −2 590 26 262 −8,98
2020-12-15 2020-12-14 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −24 986 5 163 −82,88
2020-12-15 2020-12-14 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −7 700 0 −100,00
2020-12-15 2020-12-14 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −7 252 0 −100,00
2020-12-15 2020-12-14 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −42 528 11 216 −79,13 130,14 −5 534 594 1 459 650
2020-12-15 2020-12-14 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 2 590 53 744 5,06 40,61 105 180 2 182 544
2020-12-15 2020-12-14 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 24 986 51 154 95,48 30,17 753 828 1 543 316
2020-12-15 2020-12-14 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 7 700 26 168 41,69 27,97 215 369 731 919
2020-12-15 2020-12-14 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 7 252 18 468 64,66 41,20 298 782 760 882
2020-12-11 2020-12-11 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −3 100 7 252 −29,95
2020-12-11 2020-12-11 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −3 100 11 216 −21,65 125,00 −387 500 1 402 000
2020-12-11 2020-12-11 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 3 100 14 316 27,64 41,20 127 720 589 819
2020-12-11 2020-12-10 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −100 28 852 −0,35
2020-12-11 2020-12-10 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −100 28 852 −0,35
2020-12-11 2020-12-10 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −100 30 149 −0,33
2020-12-11 2020-12-10 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −200 7 700 −2,53
2020-12-11 2020-12-10 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −500 11 216 −4,27 125,12 −62 560 1 403 346
2020-12-11 2020-12-10 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 100 11 716 0,86 40,61 4 061 475 787
2020-12-11 2020-12-10 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 100 11 616 0,87 30,17 3 017 350 455
2020-12-11 2020-12-10 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 200 11 516 1,77 27,97 5 594 322 103
2020-12-11 2020-12-10 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 100 11 316 0,89 41,20 4 120 466 219
2020-12-11 2020-12-09 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −1 873 28 952 −6,08
2020-12-11 2020-12-09 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −1 051 30 249 −3,36
2020-12-11 2020-12-09 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −400 7 900 −4,82
2020-12-11 2020-12-09 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −548 10 452 −4,98
2020-12-11 2020-12-09 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −3 872 11 216 −25,66 125,03 −484 116 1 402 336
2020-12-11 2020-12-09 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 1 873 15 088 14,17 40,61 76 063 612 724
2020-12-11 2020-12-09 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 1 051 13 215 8,64 30,17 31 709 398 697
2020-12-11 2020-12-09 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 400 12 164 3,40 27,97 11 188 340 227
2020-12-11 2020-12-09 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 548 11 764 4,89 41,20 22 578 484 677
2020-05-01 2020-04-29 4 VCEL Vericel Corp
Restricted Stock Unit
A - Award 1 750 1 750
2020-05-01 2020-04-29 4 VCEL Vericel Corp
Stock Option (right to buy)
A - Award 13 125 13 125
2020-05-01 2020-04-29 4 VCEL Vericel Corp
Restricted Stock Unit
M - Exercise −1 750 0 −100,00 14,56 −25 480
2020-05-01 2020-04-29 4 VCEL Vericel Corp
Common Stock
M - Exercise 1 750 1 750
2020-04-10 2020-04-09 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −17 226 11 000 −61,03
2020-04-10 2020-04-09 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −17 226 11 216 −60,57 88,19 −1 519 161 989 139
2020-04-10 2020-04-09 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 17 226 28 442 153,58 41,20 709 711 1 171 810
2020-04-10 2020-04-08 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −10 000 31 300 −24,21
2020-04-10 2020-04-08 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −10 000 31 300 −24,21
2020-04-10 2020-04-08 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −12 774 28 226 −31,16
2020-04-10 2020-04-08 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −4 000 0 −100,00
2020-04-10 2020-04-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −3 703 11 216 −24,82 87,50 −324 012 981 400
2020-04-10 2020-04-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −5 921 14 919 −28,41 86,79 −513 884 1 294 820
2020-04-10 2020-04-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −15 410 20 840 −42,51 85,80 −1 322 178 1 788 072
2020-04-10 2020-04-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −3 803 36 250 −9,49 84,89 −322 837 3 077 262
2020-04-10 2020-04-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −5 037 40 053 −11,17 83,68 −421 496 3 351 635
2020-04-10 2020-04-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −2 900 45 090 −6,04 82,83 −240 207 3 734 805
2020-04-10 2020-04-08 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 10 000 47 990 26,32 30,17 301 700 1 447 858
2020-04-10 2020-04-08 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 10 000 37 990 35,73 27,97 279 700 1 062 580
2020-04-10 2020-04-08 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 12 774 27 990 83,95 41,20 526 289 1 153 188
2020-04-10 2020-04-08 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 4 000 15 216 35,66 24,11 96 440 366 858
2020-01-24 2020-01-22 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 24 334 24 334
2020-01-24 2020-01-22 4 XLRN ACCELERON PHARMA INC
Common Stock
A - Award 6 369 11 216 131,40
2020-01-03 2020-01-02 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 566 4 847 −24,42 52,52 −82 246 254 564
2020-01-03 2020-01-02 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −2 300 6 413 −26,40 52,49 −120 727 336 618
2020-01-03 2020-01-02 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 713 8 713 −16,43 52,51 −89 950 457 520
2019-12-17 2019-12-13 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −11 853 10 426 −53,20 50,28 −595 969 524 219
2019-09-10 2019-09-10 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −173 22 279 −0,77 45,75 −7 915 1 019 264
2019-09-10 2019-09-10 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −7 827 22 452 −25,85 45,29 −354 485 1 016 851
2019-05-03 2019-05-01 4 VCEL Vericel Corp
Restricted Stock Unit
A - Award 1 750 1 750
2019-05-03 2019-05-01 4 VCEL Vericel Corp
Stock Option (right to buy)
A - Award 13 125 13 125
2019-04-11 2019-04-09 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −100 30 279 −0,33 45,46 −4 546 1 376 483
2019-04-11 2019-04-09 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −11 900 30 379 −28,15 44,61 −530 859 1 355 207
2019-04-04 2019-04-02 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −648 42 279 −1,51 48,02 −31 117 2 030 238
2019-01-29 2019-01-25 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 28 000 28 000
2019-01-29 2019-01-25 4 XLRN ACCELERON PHARMA INC
Common Stock
A - Award 4 700 42 927 12,29
2019-01-04 2019-01-02 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −97 38 227 −0,25 44,06 −4 274 1 684 282
2019-01-04 2019-01-02 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 717 38 324 −4,29 43,33 −74 398 1 660 579
2019-01-04 2019-01-02 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −2 186 40 041 −5,18 42,56 −93 036 1 704 145
2019-01-04 2019-01-02 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −300 42 227 −0,71 43,20 −12 960 1 824 206
2019-01-04 2019-01-02 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 412 42 527 −3,21 42,37 −59 826 1 801 869
2018-08-31 2018-08-30 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −12 500 18 300 −40,58
2018-08-31 2018-08-30 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −12 500 43 939 −22,15 54,00 −675 000 2 372 706
2018-08-31 2018-08-30 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 12 500 56 439 28,45 27,97 349 625 1 578 599
2018-07-03 2018-06-29 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −25 000 4 000 −86,21
2018-07-03 2018-06-29 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −12 500 43 939 −22,15 49,00 −612 500 2 153 011
2018-07-03 2018-06-29 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −12 500 56 439 −18,13 47,00 −587 500 2 652 633
2018-07-03 2018-06-29 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 25 000 68 939 56,90 24,11 602 750 1 662 119
2018-05-03 2018-05-02 4 VCEL Vericel Corp
Stock Option (right to buy)
A - Award 17 500 17 500
2018-04-04 2018-04-03 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −800 43 939 −1,79 39,00 −31 200 1 713 621
2018-04-04 2018-04-03 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −3 200 44 739 −6,68 38,31 −122 592 1 713 951
2018-03-05 2018-03-01 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 30 825 30 825
2018-03-05 2018-03-01 4 XLRN ACCELERON PHARMA INC
Common Stock
A - Award 5 138 47 939 12,00
2018-01-04 2018-01-04 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −200 42 801 −0,47 43,84 −8 768 1 876 396
2018-01-04 2018-01-04 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −14 800 43 001 −25,61 43,00 −636 400 1 849 043
2018-01-04 2018-01-03 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise −6 250 0 −100,00
2018-01-04 2018-01-03 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise −6 251 0 −100,00
2018-01-04 2018-01-03 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise 6 250 57 801 12,12 5,28 33 000 305 189
2018-01-04 2018-01-03 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise 6 251 51 551 13,80 3,88 24 254 200 018
2018-01-04 2018-01-02 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −4 000 45 300 −8,11 42,42 −169 680 1 921 626
2017-09-14 2017-09-12 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −210 49 300 −0,42 39,85 −8 368 1 964 605
2017-09-14 2017-09-12 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 300 49 510 −2,56 39,17 −50 921 1 939 307
2017-09-14 2017-09-12 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −14 490 50 810 −22,19 38,32 −555 257 1 947 039
2017-07-07 2017-07-05 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −18 750 0 −100,00
2017-07-07 2017-07-05 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −3 150 6 250 −33,51
2017-07-07 2017-07-05 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −34 400 65 300 −34,50 32,00 −1 100 800 2 089 600
2017-07-07 2017-07-05 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 18 750 99 700 23,16 7,12 133 500 709 864
2017-07-07 2017-07-05 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 3 150 80 950 4,05 5,28 16 632 427 416
2017-05-05 2017-05-03 4 VCEL Vericel Corp
Stock Option (right to buy)
A - Award 17 500 17 500
2017-03-14 2017-03-02 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 41 300 41 300
2017-03-14 2017-03-02 4 XLRN ACCELERON PHARMA INC
Common Stock
A - Award 6 900 77 800 9,73
2017-01-06 2017-01-04 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 300 70 900 −1,80 27,63 −35 919 1 958 967
2017-01-06 2017-01-04 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −400 72 200 −0,55 26,87 −10 748 1 940 014
2017-01-04 2017-01-03 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise −10 000 6 251 −61,53
2017-01-04 2017-01-03 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise 10 000 72 600 15,97 3,88 38 800 281 688
2016-07-07 2016-07-07 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise −5 000 16 251 −23,53
2016-07-07 2016-07-07 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise 5 000 62 600 8,68 3,88 19 400 242 888
2016-07-06 2016-07-01 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −15 300 9 400 −61,94
2016-07-06 2016-07-01 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −25 300 57 600 −30,52 34,66 −876 898 1 996 416
2016-07-06 2016-07-01 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 15 300 82 900 22,63 5,28 80 784 437 712
2016-05-25 2016-05-23 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −300 24 700 −1,20
2016-05-25 2016-05-23 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −25 300 67 600 −27,23 34,00 −860 200 2 298 400
2016-05-25 2016-05-23 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 300 92 900 0,32 5,28 1 584 490 512
2016-05-06 2016-05-04 4 VCEL Vericel Corp
Stock Option (right to buy)
A - Award 15 000 15 000
2016-03-07 2016-03-03 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 30 800 30 800
2016-03-07 2016-03-03 4 XLRN ACCELERON PHARMA INC
Common Stock
A - Award 5 100 92 600 5,83
2015-12-23 2015-12-22 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise −7 500 21 251 −26,09
2015-12-23 2015-12-22 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise 7 500 87 500 9,38 3,88 29 100 339 500
2015-10-09 2015-10-07 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −7 000 28 751 −19,58
2015-10-09 2015-10-07 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −3 460 80 000 −4,15 24,64 −85 254 1 971 200
2015-10-09 2015-10-07 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −3 540 83 460 −4,07 24,12 −85 385 2 013 055
2015-10-09 2015-10-07 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 7 000 87 000 8,75 3,88 27 160 337 560
2015-09-11 2015-09-09 4 XLRN ACCELERON PHARMA INC
Common Stock
A - Award 40 000 80 000 100,00
2015-09-10 2015-09-08 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −1 500 35 751 −4,03
2015-09-10 2015-09-08 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −5 000 37 251 −11,83
2015-09-10 2015-09-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −176 40 000 −0,44 31,16 −5 484 1 246 400
2015-09-10 2015-09-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −724 40 176 −1,77 30,45 −22 046 1 223 359
2015-09-10 2015-09-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −600 40 900 −1,45 29,39 −17 634 1 202 051
2015-09-10 2015-09-08 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 1 500 41 500 3,75 3,88 5 820 161 020
2015-09-10 2015-09-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 293 40 000 −3,13 31,07 −40 174 1 242 800
2015-09-10 2015-09-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −2 500 41 293 −5,71 30,22 −75 550 1 247 874
2015-09-10 2015-09-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 207 43 793 −2,68 29,11 −35 136 1 274 814
2015-09-10 2015-09-08 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 5 000 45 000 12,50 3,88 19 400 174 600
2015-08-12 2015-08-10 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −1 500 42 251 −3,43
2015-08-12 2015-08-10 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −5 000 43 751 −10,26
2015-08-12 2015-08-10 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 500 40 000 −3,61 28,54 −42 810 1 141 600
2015-08-12 2015-08-10 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 1 500 41 500 3,75 3,88 5 820 161 020
2015-08-12 2015-08-10 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −100 40 000 −0,25 29,23 −2 923 1 169 200
2015-08-12 2015-08-10 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −4 900 40 100 −10,89 28,51 −139 699 1 143 251
2015-08-12 2015-08-10 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 5 000 45 000 12,50 3,88 19 400 174 600
2015-07-30 2015-07-28 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise −5 000 48 751 −9,30
2015-07-30 2015-07-28 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise 5 000 40 000 14,29 3,88 19 400 155 200
2015-07-09 2015-07-07 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −2 000 53 751 −3,59
2015-07-09 2015-07-07 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −5 000 55 751 −8,23
2015-07-09 2015-07-07 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −95 35 000 −0,27 30,39 −2 887 1 063 650
2015-07-09 2015-07-07 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 905 35 095 −5,15 29,68 −56 540 1 041 620
2015-07-09 2015-07-07 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 2 000 37 000 5,71 3,88 7 760 143 560
2015-07-09 2015-07-07 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −377 35 000 −1,07 30,27 −11 412 1 059 450
2015-07-09 2015-07-07 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −4 623 35 377 −11,56 29,65 −137 072 1 048 928
2015-07-09 2015-07-07 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 5 000 40 000 14,29 3,88 19 400 155 200
2015-06-10 2015-06-10 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise −5 000 60 751 −7,60
2015-06-10 2015-06-10 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise 5 000 35 000 16,67 3,88 19 400 135 800
2015-06-09 2015-06-08 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −1 500 65 751 −2,23
2015-06-09 2015-06-08 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −5 000 67 251 −6,92
2015-06-09 2015-06-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −200 30 000 −0,66 32,96 −6 592 988 800
2015-06-09 2015-06-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 300 30 200 −4,13 32,37 −42 081 977 574
2015-06-09 2015-06-08 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 1 500 31 500 5,00 3,88 5 820 122 220
2015-06-09 2015-06-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −100 30 000 −0,33 32,97 −3 297 989 100
2015-06-09 2015-06-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −4 900 30 100 −14,00 32,49 −159 201 977 949
2015-06-09 2015-06-08 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 5 000 35 000 16,67 3,88 19 400 135 800
2015-05-13 2015-05-11 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise −5 000 72 251 −6,47
2015-05-13 2015-05-11 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −6 500 77 251 −7,76
2015-05-13 2015-05-11 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise 5 000 30 000 20,00 3,88 19 400 116 400
2015-05-13 2015-05-11 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 500 25 000 −5,66 31,78 −47 670 794 500
2015-05-13 2015-05-11 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −100 26 500 −0,38 32,40 −3 240 858 600
2015-05-13 2015-05-11 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −4 900 26 600 −15,56 31,79 −155 771 845 614
2015-05-13 2015-05-11 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 6 500 31 500 26,00 3,88 25 220 122 220
2015-04-08 2015-04-07 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −5 000 83 751 −5,63
2015-04-08 2015-04-07 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −2 000 88 751 −2,20
2015-04-08 2015-04-07 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −500 25 000 −1,96 35,50 −17 750 887 500
2015-04-08 2015-04-07 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −4 500 25 500 −15,00 34,80 −156 600 887 400
2015-04-08 2015-04-07 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 5 000 30 000 20,00 3,88 19 400 116 400
2015-04-08 2015-04-07 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −250 25 000 −0,99 35,52 −8 880 888 000
2015-04-08 2015-04-07 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 750 25 250 −6,48 34,82 −60 935 879 205
2015-04-08 2015-04-07 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 2 000 27 000 8,00 3,88 7 760 104 760
2015-03-24 2015-03-20 4 VCEL Vericel Corp
Stock Option (right to buy)
A - Award 20 000 20 000
2015-03-10 2015-03-09 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −1 500 90 751 −1,63
2015-03-10 2015-03-09 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −5 000 92 251 −5,14
2015-03-10 2015-03-09 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −200 25 000 −0,79 40,94 −8 188 1 023 500
2015-03-10 2015-03-09 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 300 25 200 −4,91 40,14 −52 182 1 011 528
2015-03-10 2015-03-09 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 1 500 26 500 6,00 3,88 5 820 102 820
2015-03-10 2015-03-09 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −619 25 000 −2,42 40,93 −25 336 1 023 250
2015-03-10 2015-03-09 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −4 381 25 619 −14,60 40,16 −175 941 1 028 859
2015-03-10 2015-03-09 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 5 000 30 000 20,00 3,88 19 400 116 400
2015-02-11 2015-02-09 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −1 500 97 251 −1,52
2015-02-11 2015-02-09 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −5 000 98 751 −4,82
2015-02-11 2015-02-09 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 500 25 000 −5,66 36,65 −54 975 916 250
2015-02-11 2015-02-09 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 1 500 26 500 6,00 3,88 5 820 102 820
2015-02-11 2015-02-09 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −400 25 000 −1,57 37,11 −14 844 927 750
2015-02-11 2015-02-09 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −4 600 25 400 −15,33 36,60 −168 360 929 640
2015-02-11 2015-02-09 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 5 000 30 000 20,00 3,88 19 400 116 400
2015-01-13 2015-01-12 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −2 000 103 751 −1,89
2015-01-13 2015-01-12 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −845 25 000 −3,27 41,04 −34 679 1 026 000
2015-01-13 2015-01-12 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 155 25 845 −4,28 40,38 −46 639 1 043 621
2015-01-13 2015-01-12 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 2 000 27 000 8,00 3,88 7 760 104 760
2015-01-09 2015-01-08 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 41 000 41 000
2015-01-09 2015-01-07 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −5 000 105 751 −4,51
2015-01-09 2015-01-07 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −4 300 25 000 −14,68 39,59 −170 237 989 750
2015-01-09 2015-01-07 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −700 29 300 −2,33 38,67 −27 069 1 133 031
2015-01-09 2015-01-07 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 5 000 30 000 20,00 3,88 19 400 116 400
2015-01-07 3 VCEL Vericel Corp
No securities are beneficially owned
0
2014-12-19 2014-12-19 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise −15 000 110 751 −11,93
2014-12-19 2014-12-19 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise 15 000 25 000 150,00 3,88 58 200 97 000
2014-12-09 2014-12-08 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −10 000 125 751 −7,37
2014-12-09 2014-12-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −100 10 000 −0,99 47,64 −4 764 476 400
2014-12-09 2014-12-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −200 10 100 −1,94 46,76 −9 352 472 276
2014-12-09 2014-12-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −300 10 300 −2,83 45,79 −13 737 471 637
2014-12-09 2014-12-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 600 10 600 −13,11 44,84 −71 744 475 304
2014-12-09 2014-12-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 100 12 200 −8,27 44,21 −48 631 539 362
2014-12-09 2014-12-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 300 13 300 −8,90 42,86 −55 718 570 038
2014-12-09 2014-12-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −200 14 600 −1,35 41,18 −8 236 601 228
2014-12-09 2014-12-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −200 14 800 −1,33 39,52 −7 904 584 896
2014-12-09 2014-12-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −196 15 000 −1,29 47,23 −9 257 708 450
2014-12-09 2014-12-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −300 15 196 −1,94 46,39 −13 917 704 942
2014-12-09 2014-12-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 000 15 496 −6,06 45,17 −45 170 699 954
2014-12-09 2014-12-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 759 16 496 −9,64 44,34 −77 994 731 433
2014-12-09 2014-12-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 344 18 255 −6,86 42,96 −57 738 784 235
2014-12-09 2014-12-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −100 19 599 −0,51 41,14 −4 114 806 303
2014-12-09 2014-12-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −201 19 699 −1,01 40,34 −8 108 794 658
2014-12-09 2014-12-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −100 19 900 −0,50 38,52 −3 852 766 548
2014-12-09 2014-12-08 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 10 000 20 000 100,00 3,88 38 800 77 600
2014-11-14 2014-11-12 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −10 000 135 751 −6,86
2014-11-14 2014-11-12 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −3 138 10 000 −23,88 33,58 −105 374 335 800
2014-11-14 2014-11-12 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 862 13 138 −12,41 32,39 −60 310 425 540
2014-11-14 2014-11-12 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −3 050 15 000 −16,90 33,60 −102 480 504 000
2014-11-14 2014-11-12 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 950 18 050 −9,75 32,44 −63 258 585 542
2014-11-14 2014-11-12 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 10 000 20 000 100,00 3,88 38 800 77 600
2014-10-27 2014-10-27 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise −10 000 145 751 −6,42
2014-10-27 2014-10-27 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise 10 000 10 000 3,88 38 800 38 800
2014-10-09 2014-10-07 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −10 000 155 751 −6,03
2014-10-09 2014-10-07 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −10 000 0 −100,00 29,25 −292 500
2014-10-09 2014-10-07 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 10 000 10 000 3,88 38 800 38 800
2014-09-10 2014-09-09 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −6 700 165 751 −3,89
2014-09-10 2014-09-09 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −370 0 −100,00 24,75 −9 158
2014-09-10 2014-09-09 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −6 330 370 −94,48 24,24 −153 439 8 969
2014-09-10 2014-09-09 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 6 700 6 700 3,88 25 996 25 996
2014-09-10 2014-09-08 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −3 300 172 451 −1,88
2014-09-10 2014-09-08 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −3 300 0 −100,00 24,90 −82 170
2014-09-10 2014-09-08 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 3 300 3 300 3,88 12 804 12 804
2014-08-15 2014-08-14 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −7 000 175 751 −3,83
2014-08-15 2014-08-14 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −3 000 182 751 −1,62
2014-08-15 2014-08-14 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −7 000 0 −100,00 29,79 −208 530
2014-08-15 2014-08-14 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 7 000 7 000 3,88 27 160 27 160
2014-08-15 2014-08-14 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −3 000 0 −100,00 29,76 −89 280
2014-08-15 2014-08-14 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 3 000 3 000 3,88 11 640 11 640
2014-07-09 2014-07-07 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −7 000 185 751 −3,63
2014-07-09 2014-07-07 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −3 000 192 751 −1,53
2014-07-09 2014-07-07 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 800 0 −100,00 32,59 −58 662
2014-07-09 2014-07-07 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −5 200 1 800 −74,29 31,42 −163 384 56 556
2014-07-09 2014-07-07 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 7 000 7 000 3,88 27 160 27 160
2014-07-09 2014-07-07 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −800 0 −100,00 32,56 −26 048
2014-07-09 2014-07-07 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −2 200 800 −73,33 31,40 −69 080 25 120
2014-07-09 2014-07-07 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 3 000 3 000 3,88 11 640 11 640
2014-06-11 2014-06-09 4 XLRN ACCELERON PHARMA INC
Option to purchase Common Stock
M - Exercise X −7 000 195 751 −3,45
2014-06-11 2014-06-09 4 XLRN ACCELERON PHARMA INC
Option to purchase Common Stock
M - Exercise X −3 000 202 751 −1,46
2014-06-11 2014-06-09 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −4 197 0 −100,00 31,98 −134 220
2014-06-11 2014-06-09 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −2 803 4 197 −40,04 31,16 −87 341 130 779
2014-06-11 2014-06-09 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 7 000 7 000 3,88 27 160 27 160
2014-06-11 2014-06-09 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 686 0 −100,00 32,00 −53 952
2014-06-11 2014-06-09 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −1 314 1 686 −43,80 31,17 −40 957 52 553
2014-06-11 2014-06-09 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 3 000 3 000 3,88 11 640 11 640
2014-05-21 2014-05-19 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −7 000 205 751 −3,29
2014-05-21 2014-05-19 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise X −3 000 212 751 −1,39
2014-05-21 2014-05-19 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −286 0 −100,00 32,17 −9 201
2014-05-21 2014-05-19 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −6 714 286 −95,91 31,49 −211 424 9 006
2014-05-21 2014-05-19 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 7 000 7 000 3,88 27 160 27 160
2014-05-21 2014-05-19 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −100 0 −100,00 32,27 −3 227
2014-05-21 2014-05-19 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale X −2 900 100 −96,67 31,48 −91 292 3 148
2014-05-21 2014-05-19 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise X 3 000 3 000 3,88 11 640 11 640
2013-12-09 2013-12-05 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 29 000 29 000
P
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
S
Åpent marked eller private kjøp av ikke-derivat eller derivat sikkerhet.
A
Bevilgning, tildeling eller andre oppkjøp av verdipapirer fra selskapet (slik som en opsjon)
C
Konvertering av derivat
D
Salg eller overføring av verdipapirer tilbake til selskapet
F
Betaling av utøvelseskurs eller skatteplikt ved å bruke deler av verdipapirer mottat fra selskapet
G
Gave av verdipapirer fra eller til insidere
K
Aksjebytting og lignende sikringsavtaler
M
Øvelse eller konvertering av derivatverdipapir mottatt fra selskapet (for eksempel en opsjon)
V
En transaksjon frivilig rapportert på Skjema 4
J
Annet (med en fotnote som beskriver transaksjonen)